103 related articles for article (PubMed ID: 16699821)
1. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential.
Lentini A; Forni C; Provenzano B; Beninati S
Amino Acids; 2007 Jan; 32(1):95-100. PubMed ID: 16699821
[TBL] [Abstract][Full Text] [Related]
2. Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.
Baldini PM; Lentini A; Mattioli P; Provenzano B; De Vito P; Vismara D; Beninati S
Melanoma Res; 2006 Dec; 16(6):501-7. PubMed ID: 17119451
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells.
Gismondi A; Lentini A; Tabolacci C; Provenzano B; Beninati S
Amino Acids; 2010 Jan; 38(1):257-62. PubMed ID: 19212807
[TBL] [Abstract][Full Text] [Related]
4. Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells.
Forni C; Braglia R; Lentini A; Nuccetelli M; Provenzano B; Tabolacci C; Beninati S
Amino Acids; 2009 Apr; 36(4):731-8. PubMed ID: 18688565
[TBL] [Abstract][Full Text] [Related]
5. Anthraquinones danthron and quinizarin exert antiproliferative and antimetastatic activity on murine B16-F10 melanoma cells.
Rossi S; Tabolacci C; Lentini A; Provenzano B; Carlomosti F; Frezzotti S; Beninati S
Anticancer Res; 2010 Feb; 30(2):445-9. PubMed ID: 20332452
[TBL] [Abstract][Full Text] [Related]
6. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S
Amino Acids; 2008 Feb; 34(2):251-6. PubMed ID: 17356804
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of the antineoplastic efficacy of 7-(2-hydroxyethyl)theophylline on melanoma cancer cells.
Lentini A; Tabolacci C; Nardi A; Mattioli P; Provenzano B; Beninati S
Melanoma Res; 2012 Apr; 22(2):133-9. PubMed ID: 22293828
[TBL] [Abstract][Full Text] [Related]
8. Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells.
Beninati S; Abbruzzese A; Cardinali M
Int J Cancer; 1993 Mar; 53(5):792-7. PubMed ID: 8095490
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic activity of strawberry (Fragaria×ananassa Duch.) crude extracts on B16-F10 melanoma cells.
Forni C; Braglia R; Mulinacci N; Urbani A; Ronci M; Gismondi A; Tabolacci C; Provenzano B; Lentini A; Beninati S
Mol Biosyst; 2014 Jun; 10(6):1255-63. PubMed ID: 24185584
[TBL] [Abstract][Full Text] [Related]
10. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
11. Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation.
Tabolacci C; Rossi S; Lentini A; Provenzano B; Turcano L; Facchiano F; Beninati S
Amino Acids; 2013 Jan; 44(1):293-300. PubMed ID: 22139409
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Di Giacomo G; Lentini A; Beninati S; Piacentini M; Rodolfo C
Amino Acids; 2009 Apr; 36(4):717-24. PubMed ID: 18594948
[TBL] [Abstract][Full Text] [Related]
14. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
Irimura T; Gonzalez R; Nicolson GL
Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
[TBL] [Abstract][Full Text] [Related]
15. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
[TBL] [Abstract][Full Text] [Related]
17. Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells.
Tabolacci C; Lentini A; Provenzano B; Gismondi A; Rossi S; Beninati S
Melanoma Res; 2010 Aug; 20(4):273-9. PubMed ID: 20404772
[TBL] [Abstract][Full Text] [Related]
18. Influence of irradiation on metabolism and metastatic potential of B16-F10 melanoma cells.
Mosch B; Mueller K; Steinbach J; Pietzsch J
Int J Radiat Biol; 2009 Nov; 85(11):1002-12. PubMed ID: 19895277
[TBL] [Abstract][Full Text] [Related]
19. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung.
Saha S; Mohanty KC
Indian J Exp Biol; 2003 Nov; 41(11):1253-8. PubMed ID: 15332492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
